Cooper Laurence James Neil (CIK 0001641506)

Latest company ownership

Shares held
1,799,280
Last filed at
Jan 6, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2016Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jan 4, 2021 Jan 6, 2021 Alaunos Therapeutics, Inc. CEO Sell 30.0 -105,693 -5.55% ✓ $286.4K
Dec 27, 2019 Dec 31, 2019 Alaunos Therapeutics, Inc. CEO Sell 30.0 -110,694 -6.00% ✓ $540.2K
Jan 6, 2019 Jan 8, 2019 Alaunos Therapeutics, Inc. CEO Sell 97.5 +618,516 52.38% ✗ $370K
Dec 29, 2018 Jan 2, 2019 Alaunos Therapeutics, Inc. CEO Sell 42.5 -85,254 -6.73% ✗ $144.9K
May 5, 2018 May 24, 2018 Alaunos Therapeutics, Inc. CEO Sell 40.0 -123,333 -8.88% ✗ $543.9K
Dec 29, 2017 Jan 3, 2018 Alaunos Therapeutics, Inc. CEO Sell 95.0 +305,665 28.20% ✗ $175.3K
Nov 8, 2017 Nov 9, 2017 Alaunos Therapeutics, Inc. CEO Buy 68.8 +6,440 0.60% ✗ $30.1K
May 5, 2017 May 9, 2017 Alaunos Therapeutics, Inc. CEO Sell 40.0 -132,000 -10.92% ✗ $939.8K
Dec 30, 2016 Jan 4, 2017 Alaunos Therapeutics, Inc. CEO Sell 95.0 +194,958 19.22% ✗ $92.5K
May 5, 2016 May 9, 2016 Alaunos Therapeutics, Inc. CEO Sell 40.0 -116,667 -10.32% ✗ $800.3K